Article info

Download PDFPDF

2SPD-011 Comparative efficacy of eptinezumab, galcanezumab, fremanezumab and erenumab in the preventive treatment of chronic migraine
Free

Authors

Citation

Claramunt García R, Muñoz Cid C, Garcia Gomez N, et al
2SPD-011 Comparative efficacy of eptinezumab, galcanezumab, fremanezumab and erenumab in the preventive treatment of chronic migraine

Publication history

  • First published May 2, 2023.
Online issue publication 
May 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.